3Uis BE,Wallis DE,Berkowitz SD,et al.Argatoban anticoagulant therapy in patients with heparin-induced thombocytopenia Circulation,2001,103(14):1838-1843
4Tsuo T,chikehira Y,Yamada T,et al.Effect of synthetic thrombin inhibitor(MD805)as an alternative drug on heparin induced thrombocytopenia during hemodialysis thromb Res,1988,52(10):165-171
二级参考文献6
1Yarovaya G A,Blokina T B,Neshkova E A. Review: Contact system. New concepts on activation mechanisms and bioregulatory functions[J].Biokhimiya, 2002,67(1):16～29.
2Diran Basmadjian, Michael V S,Susan A B.Coagulation on biomaterials in flowing blood:sone theoretical considerations[J].Biomaterials, 1997,18(23):1511～1522.
3Van Der Kamp K W H J,Van Oeveren W. Factor Ⅻ fragment and kallikrein generation in plasma during incubation with biomaterials[J]. J Biomed Mater Res, 1994,28(3): 349～352.
4Matata B M,Courtney J M,Sundaram S, et al. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factorⅫ(FⅫ): Its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes[J]. J Biomed Mater Res, 1996, 31(1): 63～70.
5Sundaram S,Irvine L,Courtney J M, et al. Modification of the influence of biomaterials on contact activation[J]. J Inter Artif Organs, 1991, 14(11): 729～731.
6Van Der Kamp K W H J,Hauch K D,Feijen J, et al. Contact activation during incubation of five different polyurethanes or glass in plasma[J]. J Biomed Mater Res, 1995, 29(10): 1303～1306.
